Polyvinyl Alcohol
CAS 9002-89-5
Polyvinyl Alcohol (CAS 9002-89-5) is a pharmaceutical compound with 0 bioactivity targets and 47 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| Polyvinyl alcohol | 8570 | SU | MTHSPL |
| POLYVINYL ALCOHOL | 8570 | SU | MTHSPL |
| polyvinyl alcohol | 8570 | SU | MTHSPL |
| Polyvinyl Alcohol | 8570 | SU | MTHSPL |
| polyvinyl alcohol | 8570 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Polyvinyl Alcohol used for in pharmaceutical contexts?
Polyvinyl Alcohol (CAS 9002-89-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Polyvinyl Alcohol?
Polyvinyl Alcohol has 47 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Radiation necrosis, Asthenia, Biliary obstruction, Bradycardia, Constipation. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Polyvinyl Alcohol also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Polyvinyl Alcohol with EU status "permitted".
What clinical phase is Polyvinyl Alcohol in?
No phase 1-4 clinical development badge is rendered for Polyvinyl Alcohol because the matched compound identifier rows do not contain a max-phase value.